{
  "version": 1,
  "sources": {
    "cpic": "https://github.com/cpicpgx/cpic-data/releases/download/v1.10/cpic_db_dump-v1.10_inserts.sql.gz",
    "dpwg": "https://api.pharmgkb.org/v1/download/file/data/dosingGuidelines.json.zip",
    "fda": "https://raw.githubusercontent.com/PharmGKB/fda-biomarker/master/fda_pgx_associations_table.json"
  },
  "activityscores": {
    "CYP2D6": [
      {
        "activityscore": 5,
        "genotypes": [
          ["*1", "*1"],
          ["*1", "*2"]
        ]
      }
    ]
  },
  "phenotypes": {
    "CYP2D6": [
      {
        "phenotype": "ultrarapid metabolizer",
        "genotypes": [
          ["*1", "*1"]
        ]
      }
    ]
  },
  "alleles": {
    "CYP2D6": [
      {
        "allele": "*2"
      }
    ]
  },
  "recommendations": {
    "cpic": {
      "abacavir": [
        {
          "factors": [
            {
              "gene": "HLA-B*57:01",
              "genotype": "positive"
            }
          ],
          "recommendation": "Use abacavir per standard dosing guidelines",
          "strength": "strong",
          "guideline": "https://cpicpgx.org/guidelines/guideline-for-abacavir-and-hla-b/"
        }
      ]
    }
  }
}